DudeDiligence.

Orchestra BioMed Holdings, Inc

OBIONASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Financing

Shares on issue

61.5M

From 35.8M in June 2024

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2024-05-15. 2 prospectus supplements filed under it since.

$100.0M

TD Securities (USA), agreement of 2024-08-12. The amount sold under this agreement is not stated apart in the 10-Q.

Warrants

8.03M

Warrants of every class.

Cash

6.4 quarters

$101.9M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-05Public offering15,000,000$5.00$75.0M424B5 ↗
2026 Q3At-the-market sales1,219,499market$6.2M10-Q ↗
2025-10-24Private placement200,000not available$20.0M8-K ↗
2025-08-01Public offering incl. 5.14M pre-funded14,550,000$2.75$40.0M424B5 ↗
2025-07-31Private placementnot availablenot available$35.0M8-K ↗